(Q34345745)

1 August 2017

title

Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients (English)

1 reference

1 August 2017

1 reference

McKee PJ

1

1 reference

1 August 2017

Blacklaw J

2

1 reference

1 August 2017

Carswell A

3

1 reference

1 August 2017

Gillham RA

4

1 reference

1 August 2017

Brodie MJ

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

36

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

257-261

1 reference

Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Effects of cimetidine on carbamazepine auto- and hetero-induction in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Controlled release carbamazepine: cognitive side effects in patients with epilepsy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Reduction of dosing frequency of carbamazepine with a slow-release preparation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Slow release carbamazepine in treatment of poorly controlled seizures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Established anticonvulsants and treatment of refractory epilepsy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

The two-period cross-over clinical trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364647

How often is medication taken as prescribed? A novel assessment technique

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1993.TB04226.X

Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses

21 January 2018

1 reference

12 December 2020

Carbamazepine (CBZ) controlled release compared with conventional CBZ: a controlled study of attention and vigilance in children with epilepsy

1 reference

12 December 2020

Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatment

1 reference

12 December 2020

Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects

1 reference

12 December 2020

Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism

1 reference

12 December 2020

Clinical monitoring during carbamazepine slow-release, once-daily monotherapy

1 reference

12 December 2020

Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation

1 reference

12 December 2020

Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine

1 reference

12 December 2020

Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study

1 reference

12 December 2020

Pharmacokinetic comparison of two carbamazepine slow-release formulations

1 reference

12 December 2020

Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects

1 reference

12 December 2020

10.1111/J.1365-2125.1993.TB04226.X

Identifiers

DOI

1 reference

release_bznpxz74x5ewzbwza6lxnxfiia

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bznpxz74x5ewzbwza6lxnxfiia

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1364647

1 reference

1 August 2017

1 reference